Datwyler - Pharma Technology Focus | Issue 117

Tested.

Proven.

Prepared.

Healthcare solutions and services that put patient safety and care first

02/23/2024 23:23:07

Home | Two years of Covid-19
In this issue
Contents
Mimotopes Company Insight
Mimotopes
CSafe Global
Briefing
Industry news
The pharma industry briefing
Covid-19 executive briefing by GlobalData
Controlant Company Insight
Controlant
Contract Pharmaceuticals Limited Canada
Comment
Ukraine: Russian invasion could cause spike in Covid-19 cases
First vaccines, now drugs: FDA’s second wave of emergency Covid-19 approvals
International Women’s Day spotlight: endometriosis
Remote audits – stopgap measure or the new normal?
Owen Mumford Company Insight
Owen Mumford
Baxter
In Depth
Two years of Covid-19: lessons the pandemic taught about delivering essential vaccines
A perfect storm: Covid-19 viral vector manufacturing adds further burden to CAR-
Russia sanctions: what next for Sputnik Covid-19 vaccine production around the w
Profit for patients: can NFTs allow people to monetise their health data?
Navigating distribution challenges for rare disease drugs
Nipro
Datwyler Company Insight
Datwyler
In Data
North America is seeing a hiring boom in pharma digital media roles
Filings buzz: 23% increase in industrial automation mentions in Q3 of 2021
Event: Outsourcing in Clinical Trials Europe 2022
Events
Next issue

03/23/2022 00:00:00